Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Alexander H. Smith

43 indexed publications match this author name.

ORCID: 0000-0002-3890-000X
OpenAlex: https://openalex.org/A5049252732

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Pharmacology 16 Safety 14 Clinical Trial 12 Depression 12 Receptor Pharmacology 12 Mechanism of Action 11 Review Article 9 Observational Study 6 Addiction 6 Brain Imaging 6 Anxiety 5 Adverse Events 5

Journals

ClinicalTrials.gov 3 bioRxiv 3 Psychopharmacology 2 Journal of psychopharmacology (Oxford, England) 2 Translational psychiatry 2 Neuropharmacology 2 bioRxiv: the preprint server for biology 1 medRxiv 1

Publication history

The "dark magic mushroom" co-produces amatoxins and psilocybin.bioRxiv: the preprint server for biology · 2026-07-22 A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adultsmedRxiv · 2026-07-19 Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.Psychopharmacology · 2026-07-01 361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized painJournal of clinical and translational science · 2026-05-20 Psychedelics in NHS services: exploring a model for real-world implementation of psilocybinThe British Journal of Psychiatry · 2026-03-30 Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain.Scientific reports · 2026-02-14 A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy VolunteersClinicalTrials.gov · 2026-02-13 The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant DepressionEmerging Minds Journal for Student Research · 2026-01-25 Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs.Journal of psychopharmacology (Oxford, England) · 2026-01-01 Electrophysiological effects of psilocybin co-administered with midazolambioRxiv · 2025-07-29 IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain.Pharmacological research · 2025-05-01 Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical ApproachPreprints.org · 2025-04-10 Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi.Journal of the American Society for Mass Spectrometry · 2025-03-05 Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative MechanismsClinicalTrials.gov · 2024-10-24 Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats.Translational psychiatry · 2024-09-30 Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.Psychedelic medicine (New Rochelle, N.Y.) · 2024-09-01 Psychedelics, Psychedelic-Assisted Therapy and Employees’ WellbeingJournal of Management Inquiry · 2024-08-28 Psilocybin as a Treatment for Anorexia Nervosa: A Pilot StudyClinicalTrials.gov · 2024-06-17 Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experiencebioRxiv · 2024-06-13 Psilocybin increases optimistic engagement over time: computational modelling of behavior in ratsbioRxiv · 2024-05-17 The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.BMC psychiatry · 2024-04-25 UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.BMJ open · 2024-03-14 Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography - tandem mass spectrometryAnalytica Chimica Acta · 2024-02-01 Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.European journal of pain (London, England) · 2024-01-01 The safety of supported psilocybin use in Oregon.Nature medicine · 2024-01-01 An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot and feasibility studies · 2023-10-05 Psychedelics: Threshold of a Therapeutic Revolution.Neuropharmacology · 2023-09-15 Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.Neuropharmacology · 2023-03-01 Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective.Journal of psychopharmacology (Oxford, England) · 2023-01-01 Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.Expert opinion on drug discovery · 2022-10-01 An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of traumaDrug Science Policy and Law · 2022-01-01 Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.Psychopharmacology · 2022-01-01 Psychedelic Identity Shift: A Critical Approach to Set And Setting.Kennedy Institute of Ethics journal · 2022-01-01 Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational psychiatry · 2021-11-08 Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Frontiers in neuroergonomics · 2021-01-01 Historic psychedelic drug trials and the treatment of anxiety disorders.Depression and anxiety · 2020-12-01 Ethics and ego dissolution: the case of psilocybin.Journal of medical ethics · 2020-05-27 Rapid-acting antidepressants.Advances in pharmacology (San Diego, Calif.) · 2019-01-01 Statistical comparison of mass spectra for identification of amphetamine-type stimulants.Forensic science international · 2017-01-01 Adolescent drug use in Wales.British journal of addiction · 1992-02-01 Hallucinogenic mushrooms.Clinical pediatrics · 1988-02-01 Production of Psilocybin in Psilocybe baeocystis Saprophytic CultureJournal of Pharmaceutical Sciences · 1965-11-01 Occurrence of psilocybin and psilocin in certain Gonocybe and Psilocybe species.Lloydia · 1962-01-01

Author directory